Join to View Full Profile
865 Northern BoulevardSuite 302Great Neck, NY 11021
Phone+1 516-708-2550
Fax+1 516-708-2597
Dr. Furie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1982 - 1984- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1979 - 1982
Weill Cornell MedicineClass of 1979
Certifications & Licensure
NY State Medical License 1980 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Newsday - Top Doctors on Long Island Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- Join now to see all
Publications & Presentations
PubMed
- Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS).Eric F Morand, Richard Furie, Martin Aringer, Laurent Arnaud, Christine Peschken
Rheumatology. 2025-11-11 - Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus.Cristina Arriens, Eric F Morand, Anca D Askanase, Richard Furie, Ronald F van Vollenhoven
Advances in Therapy. 2025-11-01 - EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update.Antonis Fanouriakis, Myrto Kostopoulou, Hans-Joachim Anders, Jeanette Andersen, Martin Aringer
Annals of the Rheumatic Diseases. 2025-10-16
Journal Articles
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus NephritisRichard Furie, Brad H Rovin, The New England Journal of Medicine
Lectures
- 6th Annual Perspectives in Rheumatic DiseasesGlobal Academy for Medical Education (Elsevier), Las Vegas, Nevada - 9/20/2013
- Advances in B Cell Biology: Rheumatoid Arthritis, Systemic Lupus Erythematosus, & VasculitisCleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Scottsdale, Arizona - 2/18/2012
Press Mentions
FDA Approves Third-Ever Drug for Lupus NephritisOctober 20th, 2025- Efgartigimod Use Extends to Myositis and Sjögren Disease in Phase 2 TrialsJune 30th, 2025
- New Data at EULAR Signal Advances in RA, Myopathy, GoutJune 27th, 2025
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
